We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms (LUTS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01457573
Recruitment Status : Completed
First Posted : October 24, 2011
Last Update Posted : July 17, 2014
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
The Methodist Hospital System

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Primary Completion Date : July 2014
  Study Completion Date : July 2014

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 April 23, 2015 May 7, 2015
2 September 22, 2015 October 21, 2015
3 June 29, 2016  
4 August 3, 2016  
5 September 12, 2016 October 27, 2016
6 September 5, 2017 October 2, 2017